William Blair Investment Management’s ANI Pharmaceuticals ANIP Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$25.2M	Buy	327,276 +10,583	+3%	+$826K	0.08%	223
2025 Q4	$25M	Sell	316,693 -31,987	-9%	-$2.77M	0.07%	242
2025 Q3	$31.9M	Sell	348,680 -141,856	-29%	-$11.6M	0.08%	201
2025 Q2	$32M	Sell	490,536 -37,740	-7%	-$2.46M	0.08%	193
2025 Q1	$35.4M	Buy	528,276 +43,008	+9%	+$2.57M	0.1%	184
2024 Q4	$26.8M	Buy	485,268 +10,440	+2%	+$599K	0.07%	273
2024 Q3	$28.3M	Sell	474,828 -14,558	-3%	-$888K	0.07%	248
2024 Q2	$31.2M	Sell	489,386 -879	-0.2%	-$57.1K	0.08%	214
2024 Q1	$33.9M	Sell	490,265 -292	-0.1%	-$17.6K	0.09%	223
2023 Q4	$27M	Sell	490,557 -9,502	-2%	-$523K	0.08%	248
2023 Q3	$29M	Sell	500,059 -39,069	-7%	-$2.25M	0.1%	224
2023 Q2	$29M	Buy	539,128 +9,998	+2%	+$443K	0.09%	236
2023 Q1	$21M	Buy	529,130 +1,665	+0.3%	+$70.2K	0.07%	276
2022 Q4	$21.2M	Sell	527,465 -19,924	-4%	-$748K	0.08%	255
2022 Q3	$17.6M	Sell	547,389 -9,665	-2%	-$331K	0.07%	266
2022 Q2	$16.5M	Sell	557,054 -14,126	-2%	-$407K	0.06%	276
2022 Q1	$16.1M	Buy	571,180 +119,736	+27%	+$4.46M	0.05%	304
2021 Q4	$20.8M	Buy	451,444 +77,338	+21%	+$3.32M	0.06%	292
2021 Q3	$12.3M	Buy	374,106 +373,351	+49,450%	+$11.6M	0.03%	349
2021 Q2	$26K	Buy	+755	New	+$25.7K	﹤0.01%	461